US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Galderma Group AG (PK) (GDERF) 銘柄情報

Galderma Group AG (PK) (GDERF)

221.22

7.32

( 3.42% )

更新日時： 03:29:22

Galderma Group AG (PK) (GDERF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

221.22

( 3.42% )

買値

212.30

売値

227.30

出来高

980

215.30 日の範囲 226.55

150.00 52 週間の範囲 248.46

時価総額

前日終値

213.90

始値

226.55

時刻

最終取引時間

03:29:22

財務取引量

US$ 216,591

VWAP

221.0116

平均取引量 (3 か月)

US$ 486,174

発行済株式数

234,568,725

配当利回り

0.44

PER

86.62

1 株当たり利益 (EPS)

2.58

歳入

5.24B

純利益

613M

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.galderma.com

本社

Zug, Switzerland

設立

1981

Galderma Group AG (PK) is listed in the sector of the その他OTC with ticker GDERF. The last closing price for Galderma (PK) was US$213.90. Over the last year, Galderma (PK) shares have traded in a share price range of US$ 150.00 to US$ 248.46.

Galderma (PK) currently has 234,568,725 shares in issue. The market capitalisation of Galderma (PK) is US$51.89 billion. Galderma (PK) has a price to earnings ratio (PE ratio) of 86.62.

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) opened a new research and...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	5.77	2.67811557206	215.45	245.97	213.9	260	245.25914213	CS
4	7.62	3.56741573034	213.6	245.97	199.95	1700	207.10725445	CS
12	27.22	14.0309278351	194	248.46	175.11	834	204.96933927	CS
26	11.024	5.24462882262	210.196	248.46	172.75	899	199.76183833	CS
52	71.22	47.48	150	248.46	150	981	190.91330082	CS
156	144.11	186.88886007	77.11	248.46	76.5463	974	175.59478681	CS
260	144.11	186.88886007	77.11	248.46	76.5463	974	175.59478681	CS

GDERF - Frequently Asked Questions (FAQ)

What is the current Galderma Group AG (PK) share price?

The current share price of Galderma Group AG (PK) is US$ 221.22

How many Galderma Group AG (PK) shares are in issue?

Galderma Group AG (PK) has 234,568,725 shares in issue

What is the market cap of Galderma Group AG (PK)?

The market capitalisation of Galderma Group AG (PK) is USD 51.89B

What is the 1 year trading range for Galderma Group AG (PK) share price?

Galderma Group AG (PK) has traded in the range of US$ 150.00 to US$ 248.46 during the past year

What is the PE ratio of Galderma Group AG (PK)?

The price to earnings ratio of Galderma Group AG (PK) is 86.62

What is the cash to sales ratio of Galderma Group AG (PK)?

The cash to sales ratio of Galderma Group AG (PK) is 10

What is the registered address of Galderma Group AG (PK)?

The registered address for Galderma Group AG (PK) is Zählerweg 10, Zug, Zug, 6300

What is the Galderma Group AG (PK) website address?

The website address for Galderma Group AG (PK) is www.galderma.com

doccjc

doccjc 34秒前

The Bashers narrative will always change.Ignore their bs . We are headed towards human trials at the Mayo Clinic .The science works .

Mrs kronwell

Mrs kronwell 2分前

PS, when I mentioned an and p at 23x, I was referencing the ootentisl upside, if management can convince street 2028- and beyond is looking good. The CFO hiring told me more than anything on that front. Doubt he’d take job if there wasn’t a pretty bright outlook!!!

Trooperstocks

Trooperstocks 2分前

$ZENA ZenaTech’s Drone as a Service (@daasplatform) attended the PGA John Deere Classic, held July 1–5, 2026, at TPC Deere Run in Silvis, Illinois.

Throughout tournament week, the DaaS team connected with golf industry professionals, local businesses, and the public as we showcased ou

Trooperstocks

Trooperstocks 3分前

$ZENA ZenaTech’s Drone as a Service (@daasplatform) attended the PGA John Deere Classic, held July 1–5, 2026, at TPC Deere Run in Silvis, Illinois.

Throughout tournament week, the DaaS team connected with golf industry professionals, local businesses, and the public as we showcased ou

DrHigh

correct. if it takes management 20 more years so be it. doesn't matter the condition of the submission. doesn't matter that they refuse to inform markets, media about this safe and effective life saving treatment. LP can do what she wants whenever she wants and we are never to question her. we work

Mr. Dragon

Mr. Dragon 4分前

The conman is back.

MightyX

MightyX 4分前

The-more yall deny obvious-facts..the-more apparent yalls lack-of desire-for-truth becomes.

gitreal

gitreal 4分前

To da MOON!!? Should investors LOAD DA BOAT?

Maybe an audit is coming? What do you think?

Mrs kronwell

Mrs kronwell 5分前

Not sure if you me a bear, if so, you’ve got one wrong. I’ve been in since 2006, added in 2010. Those are my only trades. I’ve been frustrated for sure, since I work in tech and should have reallocated some to Nvidia and honestly Apple in 2007, when sat though the greatest Preso I’ve ever seen by

joe botts

joe botts 5分前

Last time the OTC was Hot was then. Please , so many sub pennies ran.

ProfitChaser

ProfitChaser 5分前

According to the tweet a few days ago they are still moving forward. Another tweet today but the one from last week looks promissing. One of these days hopefully the company will start buying some shares or put out some info that will get the price moving up. IMO it wont take much.
From the

dexprs

That is a great idea Eric. We shall be only a few hundred miles apart and we can even meet this time around. :)

jondoeuk

jondoeuk 6分前

You are conflating multiple separate issues.

First, NWBO chose PFS as the primary endpoint. If pseudoprogression made PFS an unsuitable endpoint, that reflects a limitation of the trial design, not a reason to ignore the fact that the prespecified randomised primary endpoint was negat

callmepadrino

callmepadrino 6分前

This is the first FDA approval I’ve ever seen on the OTC as far as I can recall

SC8

Surprised they got this limited trial with the lack of good animal demos, but what a market dud on the unexpected good news. Guess people in the know realize the tech is public domain now and a competitor is over 4 years ahead to human trials. In short, Radiogel will never be a blockbuster as anyo

ignatiusrielly35

ignatiusrielly35 7分前

Yep. Up 200% in a few short months.

H~E Pennypacker

H~E Pennypacker 7分前

Just curious - what was the SS of $@#$*?

Golden Cross

Golden Cross 7分前

Large bids usually a sign we are going higher soon...

MysticProdigy77

MysticProdigy77 7分前

Can we close 0008?

SPORTYNORTY

SPORTYNORTY 7分前

Agree 100%. Well stated and wholly accurate.

TenKay

Another billion shares added to the OS…

TexasMarvL

TexasMarvL 8分前

I like BTG a lot. Last time I updated my spreadsheet BTG was 12% of my gold and silver equity holdings. Their cash flow should provide a healthy opportunity here for shareholders.
Good luck to you!

Top Penny

Top Penny 8分前

Not by a long stretch??? On what planet??? Trips to over a dollar??? I disagree, however I can see a quarter a share with $PSRU without a reverse in due time!

moczowy

moczowy 8分前

https://www.linkedin.com/posts/paul-m-michaels_reformulating-diabetes-drug-to-treat-degenerative-activity-7479951170598375424-Peve?utm_source=share&utm_medium=member_android&rcm=ACoAAC5SabIBtz_AOYFB3farfCgsByhy2x4zCeg

First Trust US Small Cap...

International bond 1.65%...

Amundi Index Solutions

Jpmorgan Chase Financial...

HSBC Global Funds ICAV

Santen Pharmaceutical (PK)

Digerati Technologies (ID)

NW Tech Capital (PK)

WisdomTree Japan Equity ...

Nine Dragons Paper (PK)

0.875% until 10mar2032

Vita Mobile Systems (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。